CT检出的壁外静脉侵犯与胃癌淋巴结转移的存在及无进展生存期相关
该研究回顾性分析105例经病理证实的胃癌患者术前CT,评估CT检出的壁外静脉侵犯(ctEMVI)与淋巴结转移及生存的关系。结果显示ctEMVI阳性与淋巴结转移独立相关(OR 9.804),且ctEMVI预测淋巴结转移的敏感度、特异度等均优于CT定义的N分期;ctEMVI阳性患者无进展生存率更低。
要点
- ctEMVI阳性者淋巴结转移风险显著增高(OR 9.804,95%CI 3.076-31.246)。
- ctEMVI预测淋巴结转移的敏感度81.7%、特异度73.3%,均优于CT N分期。
- ctEMVI阳性患者无进展生存率低于阴性者(Log-rank P=0.007)。
核心结论
- CT检出的壁外静脉侵犯与胃癌淋巴结转移及无进展生存期显著相关。
- 与CT定义的N状态相比,ctEMVI预测病理N状态的诊断效能更优。
研究设计与样本
- 回顾性分析105例经病理证实的胃癌患者,术前接受CT检查并行根治性胃切除术加扩大淋巴结清扫。
- 由两名观察者评估CT特征,采用二元logistic回归分析淋巴结转移危险因素,Kaplan-Meier法分析无进展生存。
关键影像表现/征象
- 淋巴结转移阳性组ctEMVI阳性比例高于阴性组(81.7% vs 26.7%,P<0.001)。
- 淋巴结转移阳性组肿瘤体积大于阴性组(平均体积40.77 vs 22.09 mL,P<0.001)。
- 淋巴结转移阳性组肿瘤边缘差的比例高于阴性组(45.0% vs 26.7%,P=0.054)。
- 淋巴结转移阳性组动脉期高强化比例高于阴性组(43.3% vs 26.7%,P=0.023)。
- 淋巴结转移阳性组静脉期高强化比例高于阴性组(60.0% vs 44.4%,P=0.048)。
诊断标准与关键数值
- 两名观察者评估ctEMVI和ctN状态的κ值分别为0.711和0.751。
- 胃癌患者ctEMVI阳性率为58.1%(61/105)。
- 多因素分析中ctEMVI状态预测淋巴结转移的OR为9.804(95%CI 3.076-31.246,P<0.001)。
- 肿瘤体积预测淋巴结转移的OR为1.030(95%CI 1.001-1.060,P=0.044)。
- ctEMVI预测淋巴结转移的敏感度81.7%、特异度73.3%、准确率78.1%、PPV 80.3%、NPV 75.0%,优于CT N分期的70.0%、71.1%、70.5%、76.4%、64.0%。
临床应用与阅片要点
- 阅片时可关注胃癌原发灶周围是否存在ctEMVI征象,作为淋巴结转移风险的辅助评估指标。
- ctEMVI阳性提示淋巴结转移可能性高且无进展生存期可能较差,可辅助术前精准评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study aimed to investigate if CT-detected extramural venous invasion (ctEMVI) was associated with the presence of lymph node metastasis (LNM) and survival outcomes in patients with gastric cancer.
METHODS: We retrospectively reviewed 105 patients with pathologically proved gastric cancer who underwent pre-operative CT examinations and received radical gastrectomy with extended lymphadenectomy. Differences in CT characteristics between the LNM-positive and -negative groups were assessed by two observers. Binary logistic regression analysis was performed to determine the risk factors of lymph node metastasis in gastric cancer. Progression-free survival analysis was performed by Kaplan-Meier method.
RESULTS: Two observers reached good inter-reader agreements in ctEMVI and ctN status with κ values of 0.711 and 0.751, respectively. The frequency of ctEMVI-positive status was 58.1% (61/105) in patients with gastric cancer. The LNM-positive group showed higher possibility of ctEMVI-positive status (81.7% vs 26.7%, p<0.001), larger tumor volume (mean volume, 40.77 vs 22.09 mL, p<0.001), poor tumor margin (45.0% vs 26.7% , p = 0.054) and high enhancement on arterial phase (43.3% vs 26.7%, p = 0.023) and venous phase (60.0% vs 44.4%, p = 0.048), than LNM-negative group. In multivariate analysis, ctEMVI status and tumor volume were identified as independent risk factors for lymph node metastasis with odds ratio (OR) of 9.804 (95% CI, 3.076-31.246; p<0.001) and 1.030 (95% CI, 1.001-1.060; p = 0.044). CT-detected EMVI presented better diagnostic efficiency for lymph node metastasis than CT-defined N status, with sensitivity (81.7% vs 70.0%), specificity (73.3% vs 71.1%), accuracy (78.1% vs 70.5), PPV (80.3% vs 76.4%), and NPV (75.0% vs 64.0%), respectively. Kaplan-Meier curves showed that patients with positive ctEMVI findings has lower PFS rate than patients with negative ctEMVI findings (Log-rank test, p = 0.007).
CONCLUSION: CT-detected EMVI was significantly associated with lymph node metastasis and progression free survival in patients with gastric cancer. Compared to CT-defined N status, ctEMVI provided superior diagnostic performance to predict pathologic Nstatus.
ADVANCES IN KNOWLEDGE: Our study proved that CT-detected EMVI is a promising imaging marker to predict lymph node metastasis and poor prognosis, which may contribute to the precise evaluation of gastric cancer before surgery.
引用
- Yang YT, Dong SY, Zhao J, et al. CT-detected extramural venous invasion is corelated with presence of lymph node metastasis and progression-free survival in gastric cancer. Br J Radiol. 2020. PMID: 33002375. doi:10.1259/bjr.20200673
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。